I read it as the main effort now is providing the resources as the main goal. The plans for trials and the needed drugs have been researched and close to ready with CCRO bids for trial and RFP for drug manufacturing in work .
R/S or dilution thru offerings are shareholder killers, IMO.
This leaves BTH management and Kal with those options and the "on the shelf gathering dust" FAIMS "DA" sale idea of mine/possibly others'. When was the last time any comments were made about progress being made with the POC?
Hmmm, those with the Gold make the Rules and decisions. BLO has put decisions in one hand with just Proxy or holding just 1/100th of outstanding shares there (Kal?). Owlstone with Dr Yost now may be another prospect I had not considered. But their/Owlstone personal interests aren't waiting on BTH timeline if that is excessive. IMO.
I don't see the quote AMG references that "complete prototype before seeking finance", quite the opposite IMO. I don't agree that a R/S is worth the gamble at the current PPS, which is his opinion only so far. Do others agree a R/S is a good idea?
News 
Market Data 
Discover 
